@article{Cheetham_N-2022_107916,
title = {Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors [pre-print]},
author = {Cheetham, N. and Kibble, M. and Wong, A. and Silverwood, R. and Knuppel, A. and Williams, D. and Hamilton, O. and Lee, P. and Bridger Staatz, C. and Di Gessa, G. and Zhu, J. and Katikireddi, S. and Ploubidis, G. and Thompson, E. and Bowyer, R. and Zhang, X. and Abbasian, G. and Garcia, M. and Hart, D. and Seow, J. and Graham, C. and Kouphou, N. and Acors, S. and Malim, M. and Mitchell, R. and Northstone, K. and Major-Smith, D. and Matthews, S. and Breeze, T. and Crawford, M. and Molloy, L. and Kwong, A. and Doores, K. and Chaturvedi, N. and Duncan, E. and Steves, C. and Timpson, N.},
month = {may},
year = {2022},
abstract = {SARS-CoV-2 antibody levels can be used to assess humoral immune responses following SARS-CoV-2 infection or vaccination, and may predict risk of future infection. From cross-sectional antibody testing of 9,361 individuals from TwinsUK and ALSPAC UK population-based longitudinal studies (jointly in April-May 2021, and TwinsUK only in November 2021-January 2022), we tested associations between antibody levels following vaccination and: (1) SARS-CoV-2 infection following vaccination(s); (2) health, socio-demographic, SARS-CoV-2 infection and SARS-CoV-2 vaccination variables.},
journal = {MedRxiv},
publisher = {medRxiv},
url = {https://doi.org/10.1101/2022.05.19.22275214},
}
